PilotPlan

Documented implementation, not a PilotPlan customer story

ModernaEnterprise AI and knowledge workflows

How Moderna scaled enterprise AI across scientific and business teams

A documented enterprise AI adoption case covering internal assistants, custom GPTs, clinical analysis support, policy search, and contract summarization.

The problem

Moderna wanted to increase employee capacity across scientific, clinical, legal, and business work without relying on a single central team to build every AI use case.

How it was implemented

  1. 01Started with mChat, an internal assistant built with the OpenAI API.
  2. 02Compared mChat, Microsoft Copilot, and ChatGPT Enterprise through user testing before selecting a broader platform.
  3. 03Enabled employees to create task-specific GPTs, including pilots for clinical analysis, policy questions, and contract summaries.
  4. 04Treated clinical tools as assistants intended to augment professional judgment rather than replace it.

Reported outcomes

Reported by OpenAI and the featured company. Not independently verified by PilotPlan.

  • The internal mChat tool was reportedly adopted by more than 80 percent of employees.
  • Within two months of ChatGPT Enterprise adoption, Moderna reported 750 custom GPTs across the company.
  • Forty percent of weekly active users reportedly created GPTs.
  • The source reports an average of 120 weekly ChatGPT Enterprise conversations per user.

What another team can learn

  • Compare platforms with representative users and workflows before company-wide selection.
  • A governed self-service model can uncover use cases faster than a centralized backlog alone.
  • High-stakes scientific and clinical workflows need explicit human judgment, validation, and source visibility.
  • Adoption metrics do not prove business value, so each workflow still needs outcome and risk measures.

Technical architecture

A simplified logical architecture reconstructed from the public case study. It is not claimed to be the company's private network diagram.

mChat, ChatGPT Enterprise, custom GPTs, Dose ID, Policy Bot, and Contract Companion are documented. The shared governance layer and connection pattern are inferred because detailed internal architecture is not public.

Rollout plan

A practical sequence based on documented milestones where available, with inferred and recommended steps clearly marked.

PHASE 01

Source-backed

Internal foundation

  • Launch a general internal assistant
  • Measure employee adoption and collect workflow demand

Exit gate: Usage, security, and support model understood

PHASE 02

Source-backed

Platform evaluation

  • Compare mChat, Copilot, and ChatGPT Enterprise with users
  • Select based on preference, security, and operating fit

Exit gate: Platform and governance decision

PHASE 03

Inferred

Self-service expansion

  • Enable employees to create task-specific GPTs
  • Train builders and publish approved patterns

Exit gate: Owner, data class, and review level assigned to every GPT

PHASE 04

Recommended

High-impact validation

  • Validate clinical, legal, and policy workflows separately
  • Require sources and professional review where decisions affect patients or obligations

Exit gate: Domain validation and accountable sign-off

Components and integrations

What the implementation needs, and how confidently the public evidence supports each element.

Source-backed

mChat internal assistant built with the OpenAI API

Source-backed

ChatGPT Enterprise and employee-created GPTs

Source-backed

Dose ID clinical analysis pilot, Policy Bot, and Contract Companion

Recommended

Central catalog, approval tiers, and lifecycle controls for internal GPTs

Team and responsibilities

The accountable roles needed to build, approve, and operate this kind of system.

Inferred

Central AI platform team provides the enterprise service and builder enablement

Source-backed

Business and scientific teams create domain-specific GPTs

Recommended

Clinical, legal, privacy, and security reviewers approve high-impact use

Security and operating controls

Controls explicitly documented or required to make the reconstructed implementation safe enough to operate.

Recommended

Classify use cases by impact, data sensitivity, and required review

Recommended

Require citations and human verification for clinical and legal outputs

Recommended

Maintain a registry with owner, purpose, data sources, evaluation, and retirement date

Reliability and failure handling

What should happen when the model, integration, downstream system, or generated output is wrong.

Recommended

Outdated policy answer: retrieve from governed sources and show effective dates

Recommended

Clinical reasoning error: restrict output to decision support and require qualified review

Recommended

Unowned GPT sprawl: expire or quarantine tools without an active owner and evaluation

Success metrics

Published measures are separated from the additional metrics a responsible implementation should track.

Source-backed

Weekly active users, conversations, and GPT builders

Recommended

Task completion time and correction rate by workflow

Recommended

Source coverage, reviewer agreement, and safety incidents for high-impact uses

Assumptions and unknowns

Public case studies rarely disclose full architecture, permissions, evaluation data, cost, or failure rates. These gaps must be validated before treating this as an implementation specification.

  • The published case focuses on adoption and selected workflows, not full infrastructure.
  • Usage volume does not by itself establish productivity, clinical quality, or financial return.
  • The architecture diagram groups multiple GPTs behind a conceptual governance layer.

What the source does not prove

  • The results come from an OpenAI customer story and are not independently verified here.
  • Usage and GPT counts are adoption measures, not direct proof of productivity, clinical benefit, or financial return.
  • The source does not provide complete security architecture, validation protocols, costs, or current results.

Primary source

PilotPlan summarized the implementation and added practical analysis. Read the original vendor-produced case study before relying on any claim.

Moderna enterprise AI case study by OpenAI

Questions about the Moderna implementation

How did Moderna begin its enterprise AI rollout?

It first built an internal assistant with the OpenAI API, then compared available enterprise tools through user testing before broad deployment.

What enterprise AI use cases did Moderna document?

The source describes clinical data analysis support, policy questions, contract summaries, and many employee-created GPTs across business functions.

What is the main control lesson?

Treat sensitive AI outputs as decision support, preserve source visibility, and require qualified humans to validate high-impact work.

Build an implementation plan for your actual workflow

Describe the challenge, constraints, current stack, budget, and timeline. PilotPlan researches the options and assembles a sourced implementation plan.

Start a plan